GeneDx Holdings Corp. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GeneDx Holdings Corp. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2020 to Q1 2024.
  • GeneDx Holdings Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$438K, a 100% decline year-over-year.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $186M, a 5.61% decline from 2022.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $197M, a 60% decline from 2021.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $494M, a 283% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$438K -$133M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q1 2023 $133M +$293M Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q1 2022 -$160M -$158M -6924% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$2.28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $444M Jul 10, 2020 Sep 30, 2020 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.